Current position:Product Center > Antibodies > Biosimilar Antibodies > Anti-H_CD19 hIgG1/hIgG2 Antibody(Tafasitamab)
Anti-H_CD19 hIgG1/hIgG2 Antibody(Tafasitamab)
Product Info

Cat. No:GM-28777AB

Product:Anti-H_CD19 hIgG1/hIgG2 Antibody(Tafasitamab)



Cat. No. & Size

GM-28777AB-10          10 μg

GM-28777AB-100        100 μg

GM-28777AB-1000      1mg


Description


Species Reactivity      Human

Clone                           Tafasitamab

Source/Isotype           Monoclonal human IgG1/2 hybrid Fc-domain /κ

Application                 Flow Cytometry

Specificity                   Detects CD19

Gene                            CD19

Other Names              B4, CVID3

Gene ID                       930

Background                B-lymphocyte antigen CD19, also known as CD19 molecule (Cluster of Differentiation 19), B-Lymphocyte Surface Antigen B4, T-Cell Surface Antigen Leu-12 and CVID3 is a transmembrane protein that in humans is encoded by the gene CD19. In humans, CD19 is expressed in all B lineage cells. CD19 plays two major roles in human B cells: on the one hand, it acts as an adaptor protein to recruit cytoplasmic signaling proteins to the membrane; on the other, it works within the CD19/CD21 complex to decrease the threshold for B cell receptor signaling pathways. Due to its presence on all B cells, it is a biomarker for B lymphocyte development, lymphoma diagnosis and can be utilized as a target for leukemia immunotherapies.

Storage                        Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.

Formulation                Phosphate-buffered solution, pH 7.2.

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay


Data

/ueditor/image/20240515/1715757600897434/ccfe88de84981fd19e51cf441ebb28fc.png


Relevant data
Current position:Product Center > -- > Anti-H_CD19 hIgG1/hIgG2 Antibody(Tafasitamab)
classify
Anti-H_CD19 hIgG1/hIgG2 Antibody(Tafasitamab)
Product Info

Cat. No:GM-28777AB

Product:Anti-H_CD19 hIgG1/hIgG2 Antibody(Tafasitamab)



Cat. No. & Size

GM-28777AB-10          10 μg

GM-28777AB-100        100 μg

GM-28777AB-1000      1mg


Description


Species Reactivity      Human

Clone                           Tafasitamab

Source/Isotype           Monoclonal human IgG1/2 hybrid Fc-domain /κ

Application                 Flow Cytometry

Specificity                   Detects CD19

Gene                            CD19

Other Names              B4, CVID3

Gene ID                       930

Background                B-lymphocyte antigen CD19, also known as CD19 molecule (Cluster of Differentiation 19), B-Lymphocyte Surface Antigen B4, T-Cell Surface Antigen Leu-12 and CVID3 is a transmembrane protein that in humans is encoded by the gene CD19. In humans, CD19 is expressed in all B lineage cells. CD19 plays two major roles in human B cells: on the one hand, it acts as an adaptor protein to recruit cytoplasmic signaling proteins to the membrane; on the other, it works within the CD19/CD21 complex to decrease the threshold for B cell receptor signaling pathways. Due to its presence on all B cells, it is a biomarker for B lymphocyte development, lymphoma diagnosis and can be utilized as a target for leukemia immunotherapies.

Storage                        Store at 2-8℃ short term (1-2 weeks).Store at ≤ -20℃ long term. Avoid repeated freeze-thaw.

Formulation                Phosphate-buffered solution, pH 7.2.

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay


Data

/ueditor/image/20240515/1715757600897434/ccfe88de84981fd19e51cf441ebb28fc.png


Relevant data
Tel: 400-627-9288
Message consultation
reset
submit
Service
WhatApp
Phone
Message
Message consultation
reset
submit